Richard Francis
Richard Francis is global head of Sandoz, the generic drugs division of Novartis. He is a member of the Swiss pharmaceutical company's executive committee. He joined Sandoz after a 13-year career in U.S. biotechnology firm Biogen Idec, where he led the development of several drugs to treat multiple sclerosis. Prior to that, Francis worked for Sanofi in the United Kingdom.
Latest Articles
Ensuring that no child dies for want of the right antibiotic
over 11 years ago // #HealthyMeans Living Longer
On World Pneumonia Day, it's time to turn our attention to making sure that the children most at risk of death from the disease actually receive the appropriate interventions. An exclusive commentary by Richard Francis, head of Sandoz, the generic drugs division of Swiss pharmaceutical giant Novartis.